(Q36219731)

12 August 2017

1 reference

title

Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma (English)

1 reference

12 August 2017

Andrei Maksimenko

1

1 reference

12 August 2017

Claude Malvy

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Expert Opinion on Therapeutic Targets

12 August 2017

published in

1 reference

12 August 2017

volume

9

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

825-830

1 reference

Trends in cancer incidence among children in the U.S.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Ewing tumour: incidence, prognosis and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Sequence specificity of alternating hydroyprolyl/phosphono peptide nucleic acids against zebrafish embryo mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Unlocking the potential of the human genome with RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Mechanisms of gene silencing by double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Therapeutic potentialities of EWS-Fli-1 mRNA-targeted vectorized antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Oligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Intracellular distribution of microinjected antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Potentials for RNAi in sarcoma research and therapy: Ewing's sarcoma as a model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

Killing the messenger: antisense DNA and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

The Ewing's sarcoma protein interacts with the Tudor domain of the survival motor neuron protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.825

21 January 2018

Identifiers

DOI

10.1517/14728222.9.4.825

1 reference

12 August 2017

1 reference